Efthymios Chalkias

Dr. Efthymios Chalkias

AHEPA University Hospital, Thessaloníki, Kentrikí Makedonía, Greece
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
ECEfthymios Chalkias
Efthymios Chalkias
ICIOANNIS NIKOLAOS CHALKIAS
IOANNIS NIKOLAOS CHALKIAS
Christos BakirtzisChristos Bakirtzis
Christos Bakirtzis
Lambros MessinisLambros Messinis
Lambros Messinis
Grigorios NasiosGrigorios Nasios
Grigorios Nasios
DPDemetrios Pirounides
Demetrios Pirounides
Alzheimer’s disease and vascular dementia account for the majority of cases of cognitive decline in elderly people. These two main forms of dementia, under which various subtypes fall, are often overlapping and, in some cases, definitive diagnosis may only be possible post-mortem. This has implications for the quality of care and the design of individualized interventions for these patients. Optical coherence tomography angiography (OCTA) is a non-invasive imaging modality used to visualize the retinal layers and vessels which shows encouraging results in the study of various neurological conditions, including dementia. This review aims to succinctly sum up the present state of knowledge and provide critical insight into emerging patterns of OCTA biomarker values in Alzheimer’s disease and vascular dementia. According to the current literature, vessel density seems to be a common biomarker for both forms; inner retinal layer thickness might represent a biomarker preferentially affected in degenerative dementia including Alzheimer’s, while, in contrast, the outer-layer thickness as a whole justifies attention as a potential vascular dementia biomarker. Radial peripapillary capillary density should also be further studied as a biomarker specifically linked to vascular dementia.